RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chemometec A/S Stock

Chemometec A/S EBIT 2024

Chemometec A/S EBIT

168.96 M DKK

Ticker

CHEMM.CO

ISIN

DK0060055861

WKN

A0MS80

In 2024, Chemometec A/S's EBIT was 168.96 M DKK, a -26.74% increase from the 230.64 M DKK EBIT recorded in the previous year.

The Chemometec A/S EBIT history

YEAREBIT (undefined DKK)
2027e-
2026e192.61
2025e197.25
2024168.96
2023230.64
2022202.76
2021116.85
202077.18
201954.03
201824.28
201710.42
201615.9
20155.83
20141.6
20131.5
2012-11.5
20110.8
2010-1.6
20092.1
200814.8
20071.4
20060.8
20050.1

Chemometec A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Chemometec A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chemometec A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chemometec A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Chemometec A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Chemometec A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Chemometec A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chemometec A/S’s growth potential.

Chemometec A/S Revenue, EBIT and net profit per share

DateChemometec A/S RevenueChemometec A/S EBITChemometec A/S Net Income
2027e578.86 M undefined0 undefined0 undefined
2026e538.18 M undefined192.61 M undefined154.15 M undefined
2025e468.65 M undefined197.25 M undefined156.93 M undefined
2024407.87 M undefined168.96 M undefined136.28 M undefined
2023444.4 M undefined230.64 M undefined178.67 M undefined
2022428.39 M undefined202.76 M undefined159.47 M undefined
2021281.13 M undefined116.85 M undefined88.35 M undefined
2020214.1 M undefined77.18 M undefined59.16 M undefined
2019175.51 M undefined54.03 M undefined41.85 M undefined
2018112.69 M undefined24.28 M undefined18.22 M undefined
201790.33 M undefined10.42 M undefined7.49 M undefined
201685.23 M undefined15.9 M undefined10.48 M undefined
201561.24 M undefined5.83 M undefined7.95 M undefined
201445.2 M undefined1.6 M undefined1.2 M undefined
201341.4 M undefined1.5 M undefined300,000 undefined
201239.2 M undefined-11.5 M undefined-9.9 M undefined
201137.2 M undefined800,000 undefined100,000 undefined
201032.6 M undefined-1.6 M undefined-3.7 M undefined
200932.1 M undefined2.1 M undefined4.6 M undefined
200844.8 M undefined14.8 M undefined13.2 M undefined
200722.3 M undefined1.4 M undefined1.1 M undefined
200614.6 M undefined800,000 undefined4.1 M undefined
200513.9 M undefined100,000 undefined-1 M undefined

Chemometec A/S stock margins

The Chemometec A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemometec A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemometec A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Chemometec A/S's sales revenue. A higher gross margin percentage indicates that the Chemometec A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Chemometec A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Chemometec A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chemometec A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chemometec A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chemometec A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Chemometec A/S Margin History

Chemometec A/S Gross marginChemometec A/S Profit marginChemometec A/S EBIT marginChemometec A/S Profit margin
2027e78.8 %0 %0 %
2026e78.8 %35.79 %28.64 %
2025e78.8 %42.09 %33.49 %
202478.8 %41.43 %33.41 %
202378.91 %51.9 %40.2 %
202280.06 %47.33 %37.23 %
202181.78 %41.57 %31.43 %
202078.56 %36.05 %27.63 %
201976.65 %30.78 %23.84 %
201870.3 %21.55 %16.16 %
201766.47 %11.53 %8.29 %
201665.48 %18.65 %12.3 %
201563.46 %9.52 %12.98 %
201465.04 %3.54 %2.65 %
201366.43 %3.62 %0.72 %
201266.58 %-29.34 %-25.26 %
201168.82 %2.15 %0.27 %
201064.42 %-4.91 %-11.35 %
200961.99 %6.54 %14.33 %
200869.42 %33.04 %29.46 %
200756.5 %6.28 %4.93 %
200658.9 %5.48 %28.08 %
200551.08 %0.72 %-7.19 %

Chemometec A/S Aktienanalyse

What does Chemometec A/S do?

Chemometec A/S is an internationally active company based in Allerød, Denmark, specializing in the development and distribution of instruments and solutions for cell counting and analysis. The company was founded in 1997 by Tine Kjeldsen and Steen Søndergaard and has since had a remarkable growth story. Chemometec A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Chemometec A/S's EBIT

Chemometec A/S's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Chemometec A/S's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Chemometec A/S's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Chemometec A/S’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Chemometec A/S stock

How much did Chemometec A/S achieve in EBIT for the current year?

In the current year, Chemometec A/S has achieved an EBIT of 168.96 M DKK.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Chemometec A/S.

How has the EBIT of Chemometec A/S developed in recent years?

The EBIT of Chemometec A/S has increased by -26.741% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Chemometec A/S?

The EBIT of Chemometec A/S is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Chemometec A/S pay?

Over the past 12 months, Chemometec A/S paid a dividend of 6 DKK . This corresponds to a dividend yield of about 1.44 %. For the coming 12 months, Chemometec A/S is expected to pay a dividend of 6 DKK.

What is the dividend yield of Chemometec A/S?

The current dividend yield of Chemometec A/S is 1.44 %.

When does Chemometec A/S pay dividends?

Chemometec A/S pays a quarterly dividend. This is distributed in the months of March, November, November, November.

How secure is the dividend of Chemometec A/S?

Chemometec A/S paid dividends every year for the past 0 years.

What is the dividend of Chemometec A/S?

For the upcoming 12 months, dividends amounting to 6 DKK are expected. This corresponds to a dividend yield of 1.44 %.

In which sector is Chemometec A/S located?

Chemometec A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chemometec A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chemometec A/S from 10/17/2023 amounting to 6 DKK, you needed to have the stock in your portfolio before the ex-date on 10/13/2023.

When did Chemometec A/S pay the last dividend?

The last dividend was paid out on 10/17/2023.

What was the dividend of Chemometec A/S in the year 2023?

In the year 2023, Chemometec A/S distributed 0 DKK as dividends.

In which currency does Chemometec A/S pay out the dividend?

The dividends of Chemometec A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Chemometec A/S stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Chemometec A/S

Our stock analysis for Chemometec A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemometec A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.